Anterix Inc. ATEX
81.42
0.09
0.11%
as of 25 Sep
- Market cap
- $1.6B
- P/E
- 23.2×
Follow ATEX
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
50.41% | 42.72% | 43.27% | 27.92% | |
| 25.93% | 21.87% | 22.71% | 15.32% | ||
ROIC |
30.92% | 25.28% | 35.84% | 26.21% | |
Return on Tangible Assets |
379.48% | 543.28% | 106.86% | 53.72% | |
Average Days of Receivables |
465.04 | 535.44 | 597.27 | 739.54 | |
Free Cash Flow per Share |
(2.69) | (2.78) | (1.16) | (1.01) | |
Free Cash Flow |
(50.33) | (51.93) | (21.74) | (19.33) | |
Capital Expenditures |
(24.34) | (25.37) | (27.25) | (30.02) | |
Piotroski F-Score |
2.00 | 2.00 | 5.00 | 5.00 | |
| Other line items | |||||
Cash ROIC |
(9.30%) | (10.01%) | 1.53% | 2.66% | |
Accounts Receivable Turnover |
0.60 | 0.70 | 0.63 | 0.72 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.06) | (0.05) | (0.05) | (0.10) | |
Research and Development Expense of Revenue |
76.64% | 76.28% | 72.34% | 68.21% | |
Selling, General and Administrative Expense of Revenue |
727.68% | 719.79% | 660.87% | 604.40% | |
Share Based Compensation of Revenue |
208.54% | 197.34% | 176.76% | 158.23% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
(0.27) | (0.33) | 0.06 | 0.16 | |
Depreciation/Fixed assets |
0.47 | 0.47 | 0.56 | 0.58 | |
Capex/Depreciation |
(51.24) | (58.05) | (58.73) | (68.08) | |
Revenue per Share |
0.32 | 0.32 | 0.35 | 0.37 | |
Operating CF per Share |
(1.39) | (1.42) | 0.29 | 0.56 | |
Capex per Share |
(1.30) | (1.36) | (1.46) | (1.57) | |
Capex to Sales |
4.11 | 4.28 | 4.19 | 4.26 | |
Net Profit Margin |
1,614.08% | 1,370.92% | 1,394.17% | 933.04% |
Columns are period end dates